SLNO SOLENO THERAPEUTICS INC
Price Chart
Executive Summary
Soleno Therapeutics' shelf registration statement on Form S-3 (File No. 333-275120) was declared effective by the SEC on May 27, 2026. This allows the company to offer and sell up to an undisclosed amount of securities from time to time, creating a potential near-term dilution overhang for existing shareholders.
Actionable Insight
Monitor for a follow-on pricing press release or prospectus supplement. At-the-market or block offerings could weigh on SLNO shares. Given the bearish consensus and pre-revenue status, any near-term equity raise would likely be dilutive.
Key Facts
- Form S-3 shelf registration (File No. 333-275120) became effective on May 27, 2026
- Company can now sell shares, debt, or other securities at its discretion over time
- Pre-revenue clinical-stage biotech with 80% analyst Hold/Sell/Strong Sell consensus (0% bullish)
Financial Impact
Undisclosed — shelf registration allows flexible capital raising; no specific offering size or pricing disclosed
Risk Factors
- Imminent equity offering could dilute existing shareholders materially
- No cash runway or burn rate disclosed — with no approved products, capital needs are likely
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001764 |
| Document: 9999999995-26-001764-index.html | 9999999995-26-001764 |
| Document: 9999999995-26-001764.txt | 9999999995-26-001764 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 28, 2026
9d ago
|
15-12G
| — | awaiting T+1 | — | — |
|
May 28, 2026
9d ago
|
EFFECT
| — | awaiting T+1 | — | — |
|
May 18, 2026
19d ago
|
8-K / 25-NSE
| $53.01 $53.01 | · 0.00% | ▲ +0.65% | — |
|
Apr 7, 2026
8w ago
|
8-K
| $52.35 $52.60 | ▼ −0.48% | ▲ +2.06% | — |
|
Apr 6, 2026
8w ago
|
8-K
| $52.25 $52.35 | ▲ +0.19% | ▲ +0.13% | — |
|
Mar 27, 2026
10w ago
|
Insider Cluster
| $30.05 $30.44 | ▲ +1.30% | ▲ +1.66% | — |
|
Feb 26, 2026
14w ago
|
8-K
| $38.09 $39.07 | ▲ +2.57% | ▲ +3.03% | — |
|
Feb 25, 2026
14w ago
|
8-K
| $41.01 $38.09 | ▼ −7.12% | ▼ −6.57% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access